Banerjee S - Search Results

1

New strategies in the treatment of ovarian cancer: current clinical perspectives and future potential.

Banerjee S, Kaye SB. Banerjee S, et al. Clin Cancer Res. 2013 Mar 1;19(5):961-8. doi: 10.1158/1078-0432.CCR-12-2243. Epub 2013 Jan 10. Clin Cancer Res. 2013. PMID: 23307860 Review.

2

The effects of neoadjuvant anastrozole and tamoxifen on circulating vascular endothelial growth factor and soluble vascular endothelial growth factor receptor 1 in breast cancer.

Banerjee S, Pancholi S, A'hern R, Ghazoui Z, Smith IE, Dowsett M, Martin LA. Banerjee S, et al. Clin Cancer Res. 2008 May 1;14(9):2656-63. doi: 10.1158/1078-0432.CCR-07-1352. Clin Cancer Res. 2008. PMID: 18451229 Clinical Trial.

3

The future of targeted therapies in ovarian cancer.

Banerjee S, Gore M. Banerjee S, et al. Oncologist. 2009 Jul;14(7):706-16. doi: 10.1634/theoncologist.2009-0013. Epub 2009 Jul 10. Oncologist. 2009. PMID: 19592450 Free article. Review.

4

Targeted therapies as adjuvant treatment for early-stage colorectal cancer: first impressions and clinical questions.

Banerjee S, Cunningham D. Banerjee S, et al. Clin Colorectal Cancer. 2010 Jun;9 Suppl 1:S28-35. doi: 10.3816/CCC.2010.s.004. Clin Colorectal Cancer. 2010. PMID: 20630848 Review.

5

Biological evidence for dual antiangiogenic-antiaromatase activity of the VEGFR inhibitor PTK787/ZK222584 in vivo.

Banerjee S, A'Hern R, Detre S, Littlewood-Evans AJ, Evans DB, Dowsett M, Martin LA. Banerjee S, et al. Clin Cancer Res. 2010 Aug 15;16(16):4178-87. doi: 10.1158/1078-0432.CCR-10-0456. Epub 2010 Aug 3. Clin Cancer Res. 2010. PMID: 20682704 Free article.

6

Making the best of PARP inhibitors in ovarian cancer.

Banerjee S, Kaye SB, Ashworth A. Banerjee S, et al. Nat Rev Clin Oncol. 2010 Sep;7(9):508-19. doi: 10.1038/nrclinonc.2010.116. Epub 2010 Aug 10. Nat Rev Clin Oncol. 2010. PMID: 20700108 Review.

7

PARP inhibitors in BRCA gene-mutated ovarian cancer and beyond.

Banerjee S, Kaye S. Banerjee S, et al. Curr Oncol Rep. 2011 Dec;13(6):442-9. doi: 10.1007/s11912-011-0193-9. Curr Oncol Rep. 2011. PMID: 21913063 Review.

8

The role of targeted therapy in ovarian cancer.

Banerjee S, Kaye S. Banerjee S, et al. Eur J Cancer. 2011 Sep;47 Suppl 3:S116-30. doi: 10.1016/S0959-8049(11)70155-1. Eur J Cancer. 2011. PMID: 21943965 Review.

9

Molecular targets and targeted therapeutics in endometrial cancer.

Weigelt B, Banerjee S. Weigelt B, et al. Among authors: banerjee s. Curr Opin Oncol. 2012 Sep;24(5):554-63. doi: 10.1097/CCO.0b013e328354e585. Curr Opin Oncol. 2012. PMID: 22581357 Review.

10

Recent advances in systemic treatments for ovarian cancer.

Banerjee S, Gore M. Banerjee S, et al. Cancer Imaging. 2012 Sep 28;12(2):305-9. doi: 10.1102/1470-7330.2012.9002. Cancer Imaging. 2012. PMID: 23022887 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,313 results

Search Page

Filters